Standard InChI: InChI=1S/C48H61N13O8/c49-40(62)27-37(42(50)64)60-43(65)35(13-6-22-55-47(51)52)58-45(67)39-15-8-24-61(39)46(68)36(14-7-23-56-48(53)54)59-44(66)38(25-29-16-18-32(19-17-29)30-9-2-1-3-10-30)57-41(63)28-69-34-21-20-31-11-4-5-12-33(31)26-34/h1-5,9-12,16-21,26,35-39H,6-8,13-15,22-25,27-28H2,(H2,49,62)(H2,50,64)(H,57,63)(H,58,67)(H,59,66)(H,60,65)(H4,51,52,55)(H4,53,54,56)/t35-,36-,37-,38-,39-/m0/s1
1.Takayama K,Mori K,Asari T,Sohma Y,Nomura E,Sasaki Y,Taguchi A,Taniguchi A,Miyazato M,Minamino N,Kangawa K,Hayashi Y. (2020) Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability., 30 (18):[PMID:32721452][10.1016/j.bmcl.2020.127436]